Duyang Gao et al.
Theranostics, 9(18), 5315-5331 (2019-08-15)
Background: Engineering a single organic-molecule-based nanoparticle integrating precise diagnosis and effective therapy is of great significance for cancer treatment and future clinical applications but remains a great challenge. The goal of this study is to explore small organic molecule-based nanoparticles...
[Determination of 3-bromobenzaldehyde, 3-phenoxybenzaldehyde and 3-phenoxybenzyl alcohol in the air of the work place].
N Ia Smoliar
Gigiena i sanitariia, (2)(2), 69-69 (1990-02-01)
Antara Garai et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 24(48), 12613-12622 (2018-06-09)
Metal- versus ligand-centered redox processes and the effects of substituents on the ligands on the spectroscopic properties of the metal complexes are at the heart of research on metal complexes with non-innocent ligands. This work presents three examples of chromium...
J P Fernandez et al.
Journal of medicinal chemistry, 26(9), 1317-1319 (1983-09-01)
Molecular biotransformation of 2-phenylthiazolidine (1) and its m-bromo derivative (2) in the mouse is followed by autoradiographic studies and assessed by analysis of urinary metabolites. Cysteamine (4) is one of the metabolites of compounds 1 and 2. Radioprotective activity and...
Subhasish Tapadar et al.
Bioorganic & medicinal chemistry, 23(24), 7543-7564 (2015-11-21)
Inhibition of the enzymatic activity of histone deacetylase (HDAC) is a promising therapeutic strategy for cancer treatment and several distinct small molecule histone deacetylase inhibitors (HDACi) have been reported. We have previously identified a new class of non-peptide macrocyclic HDACi...